FAP and amyloidosis: Since the protective feature of hemodialysis on the progression of amyloidosis is not due to the clearance of this abnormal protein from plasma [58], we suggest that plasma glycation agents are removed by hemodialysis and so their contribution to FAP decreases after this procedure.